taspoglutide Articles

Blow for Ipsen as Roche drops taspoglutide, but good news on IB1001, as French drugmaker posts 5% rise in 2010 sales

3 February 2011

Type 2 diabetes drug market to nearly double to $36 billion in 2019, boosted by news drugs; research shows many patients not taking their insulin

23 September 2010

Highlights of ADA meeting see good results for canagliflozin, Victoza, dapagliflozin, Lantus & Apidra and taspoglutide

28 June 2010

Roche/Ipsen’s diabetes drug taspoglutide stumbles on safety grounds, meaning delay in approval

21 June 2010

Roche’s Tarceva cleared for NSCLS maintenance in EU; taspoglutide positive in Ph III diabetes trial; milestone for Osiris from JCR

30 April 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end